Advances and challenges in developing cytokine fusion proteins as improved therapeutics

Author： Chang Chien-Hsing Gupta Pankaj Goldenberg David M

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.4, Iss.2, 2009-02, pp. : 181-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Current Status and Challenges in the Development of Fusion Inhibitors as Therapeutics for HIV-1 Infection

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1810-1817

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges and Strategies in Developing Microneedle Patches for Transdermal Delivery of Protein and Peptide Therapeutics

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 7, 2012-06 ,pp. : 1292-1298

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokine Therapeutics for Infectious Diseases

Current Pharmaceutical Design, Vol. 6, Iss. 6, 2000-04 ,pp. : 665-680

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Cytokine Therapeutics: History and Update

Current Pharmaceutical Design, Vol. 15, Iss. 17, 2009-06 ,pp. : 1998-2025

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor-Based Design of Cytokine Therapeutics

Current Pharmaceutical Biotechnology, Vol. 4, Iss. 1, 2003-02 ,pp. : 1-20

Bentham Science Publishers

Access to resources Recommend Favorite